 Veru stock skyrocketed Monday after the Food and Drug Administration posted a mixed review of its repurposed cancer drug for Covid treatment. The post Medical Leader Veru Catapults As FDA Preps To Discuss Cancer Drug For Covid appeared first on Investors Business Daily. 